Histologic Features of Melanocytic Nevi Secondary to Melanoma Treatment With Immune Checkpoint Inhibitors
Cureus · 17.03.2026
DOI: 10.7759/cureus.105392 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 17.03.2026. Verfasst von Nehaa Sohail und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Education, Texas Tech University Health Sciences Center Paul L. Foster School of Medicine, El Paso, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Education, Texas Tech University Health Sciences Center Paul L. Foster School of Medicine, El Paso, USA.
- Medical Education, McGovern Medical School, The University of Texas Health Science Center, Houston, USA.
- Medical Education, Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine, El Paso, USA.
- Pathology and Laboratory Medicine, Pathology Professional Services, El Paso, USA.
- Department of Dermatology, El Paso Dermatology, El Paso, USA.
Zitieren
APA
Sohail, N., Sohail, A., Durrani, S., Bilbaoa, J., Abbud, C. A., Simpson, B., & Reyes Barron, C. (2026). Histologic Features of Melanocytic Nevi Secondary to Melanoma Treatment With Immune Checkpoint Inhibitors. Cureus. https://doi.org/10.7759/cureus.105392
Vancouver
Sohail N, Sohail A, Durrani S, Bilbaoa J, Abbud CA, Simpson B, et al. Histologic Features of Melanocytic Nevi Secondary to Melanoma Treatment With Immune Checkpoint Inhibitors. Cureus. 2026. doi:10.7759/cureus.105392
BibTeX
@article{Sohail2026,
author = {Sohail, Nehaa and Sohail, Ayaan and Durrani, Sanaa and Bilbaoa, Jorge and Abbud, Cesar A and Simpson, Brenda and Reyes Barron, Cynthia},
title = {Histologic Features of Melanocytic Nevi Secondary to Melanoma Treatment With Immune Checkpoint Inhibitors},
journal = {Cureus},
year = {2026},
doi = {10.7759/cureus.105392}
}
EUVIMED